Work

Inflammation and immunogenicity limit the utility of the rabbit as a nonclinical species for ocular biologic therapeutics

Year: 2017

Type: article

Source: Regulatory Toxicology and Pharmacology

DOI: 10.1016/j.yrtph.2017.03.013

Authors: Christina L.Zuch de Zafra, Vito G. Sasseville, Steven Matsumoto, Christian Freichel, Mark Milton, Timothy K. MacLachlan, Cindy Farman, Iona Raymond, Swati Gupta, Ronald Newton, Elke-Astrid Atzpodien, Evan A. Thackaberry

Institutions: Genentech, Allergan (United States), F. Hoffmann-La Roche AG, Novartis Institutes for BioMedical Research

Language: English

Topic: Animal testing and alternatives

Subfield: Small Animals

Field: Veterinary

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2596307615

FWCI: 7.324

Cites: 44

Cited by: 39

Related to: 10